These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 11823338)

  • 21. Some pharmacological aspects of depot neuroleptics.
    Lingjaerde O
    Acta Psychiatr Scand Suppl; 1973; 246():9-14. PubMed ID: 4520280
    [No Abstract]   [Full Text] [Related]  

  • 22. Large variations of plasma levels during maintenance treatment with depot neuroleptics.
    Tuninger E; Levander S
    Br J Psychiatry; 1996 Nov; 169(5):618-21. PubMed ID: 8932892
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Flupenthixol poisoning. The patient drank a depot preparation intended for intramuscular injection].
    Danielsson BR; Jerling M
    Lakartidningen; 1992 Feb; 89(8):574-7. PubMed ID: 1740955
    [No Abstract]   [Full Text] [Related]  

  • 24. Comparison of antipsychotic depot injections in the maintenance treatment of schizophrenia.
    Carney MW; Sheffield BF
    Br J Psychiatry; 1976 Nov; 129():476-81. PubMed ID: 990663
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Flupenthixol and the out-patient maintenance treatment of schizophrenia.
    Freeman HL
    Br J Psychiatry; 1973 Jan; 122(566):121-2. PubMed ID: 4683017
    [No Abstract]   [Full Text] [Related]  

  • 26. [Dose and serum drug level and its clinical effects during the long-term treatment of chronic schizophrenia with flupenthixol depot].
    Lipska B; Szukalski B; Nurowska K; Welbel L
    Psychiatr Pol; 1986; 20(1):1-7. PubMed ID: 3725983
    [No Abstract]   [Full Text] [Related]  

  • 27. Mudi-chood.
    Ashique KT
    Indian J Dermatol Venereol Leprol; 2014; 80(3):254. PubMed ID: 24823405
    [No Abstract]   [Full Text] [Related]  

  • 28. A comparative trial of depot pipothiazine.
    Steinert J; Neder A; Erba E; Pugh CR; Robinson C; Priest RG
    J Int Med Res; 1986; 14(2):72-7. PubMed ID: 2870944
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Experiences with Fluanxol-depot ampules in the treatment of patients with chronic psychoses].
    Schwalbe W
    Z Allgemeinmed; 1971 Dec; 47(36):1919-22. PubMed ID: 5142254
    [No Abstract]   [Full Text] [Related]  

  • 30. Combining depot antipsychotic with an assertive monitoring programme for treating first-episode schizophrenia in a resource-constrained setting.
    Chiliza B; Ojagbemi A; Esan O; Asmal L; Oosthuizen P; Kidd M; Gureje O; Emsley R
    Early Interv Psychiatry; 2016 Feb; 10(1):54-62. PubMed ID: 24690088
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Fluanxol Depot in the schizophrenia maintenance treatment.
    Ciurezu T; Niţurad A; Sârbulescu A
    Rom J Neurol Psychiatry; 1991; 29(3-4):221-3. PubMed ID: 1820107
    [No Abstract]   [Full Text] [Related]  

  • 32. [Anaphylaxis caused by carboxymethylcellulose: report of 2 cases of shock from injectable corticoids].
    Beaudouin E; Kanny G; Gueant JL; Moneret-Vautrin DA
    Allerg Immunol (Paris); 1992 Nov; 24(9):333-5. PubMed ID: 1285842
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Bullous toxicoderma (bullous allergoderma) after sulfamide-retard (associated with profuse herpes)].
    Témime P
    Bull Soc Fr Dermatol Syphiligr; 1967; 74(5):580-1. PubMed ID: 4297495
    [No Abstract]   [Full Text] [Related]  

  • 34. The duration of maintenance therapy in chronic schizophrenia.
    Johnson DA
    Acta Psychiatr Scand; 1976 Apr; 53(4):298-301. PubMed ID: 1274649
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Intervals between hospitalisations in schizophrenia patients under antipsychotics in depot-form versus oral second generation antipsychotics].
    Gutwinski S; Müller P; Koller M
    Psychiatr Prax; 2007 Sep; 34(6):289-91. PubMed ID: 17806015
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Depot-neuroleptics].
    van Praag HM
    Ned Tijdschr Geneeskd; 1971 Apr; 115(15):672-3. PubMed ID: 5551425
    [No Abstract]   [Full Text] [Related]  

  • 37. Local and systemic adverse skin reactions following the use of herbal products believed to contain Nigella sativa seeds and oil.
    Dehavay F; Kolivras A; Scheers C
    Contact Dermatitis; 2019 Mar; 80(3):176-177. PubMed ID: 30478848
    [No Abstract]   [Full Text] [Related]  

  • 38. [Anesthesia in patients using depot-preparation neuroleptics].
    Lingjaerde O; Innes RK
    Tidsskr Nor Laegeforen; 1972 Jun; 92(16):1131. PubMed ID: 5037667
    [No Abstract]   [Full Text] [Related]  

  • 39. Assessment of drugs in schizophrenia. Assessment of depot neuroleptics.
    Daniel GR
    Br J Clin Pharmacol; 1976 Jun; 3(3 Suppl 2):417-21. PubMed ID: 791327
    [No Abstract]   [Full Text] [Related]  

  • 40. [Allergic contact eczema to etofenamate and dwarf pine oil].
    Knöll R; Ulrich R; Spallek W
    Sportverletz Sportschaden; 1990 Jun; 4(2):96-8. PubMed ID: 2143316
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.